 |
GREGORY J. SZPUNAR, R.Ph., Ph.D.
Senior Vice President, Pharmaceutical Sciences
Schering-Plough Research Institute
Schering-Plough Corporation
Kenilworth, New Jersey
Gregory J. Szpunar, R.Ph., Ph.D., is senior vice president,
Pharmaceutical Sciences, Schering-Plough Research Institute.
Szpunar was named to his current position at Schering-Plough in October 2007.
In this capacity he leads formulation development, chemical and biological process development,
clinical supplies manufacture/logistics and the transfer of all processes to global operations.
Before joining Schering-Plough, Szpunar was Chief Scientific Officer and
senior vice president for R&D/Manufacturing at Biovail Corporation. Szpunar began his
pharmaceutical career at The Upjohn Company where he held leadership positions overseeing
pharmacokinetic and biopharmaceutic research. He was named vice president Worldwide Drug Metabolism
when the organization became Pharmacia & Upjohn, and later was senior vice president,
Product Development, for Pharmacia Corporation.
Szpunar earned a B.S. degree in pharmacy in 1980 from Wayne State University,
where he graduated with high distinction. In 1984, he received a Ph.D. degree in pharmaceutics
from the University of Michigan.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
|
|
